Sex differences in cardio-kidney metabolic syndrome: insights from the FINE-HEART pooled analysis of >18,000 trial participants

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Maria Pabon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on inflammation and cardiovascular disease

Professor J. Deanfield (London, GB)

Presentation thumbnail

Combined therapy of SGLT2i and GLP1ra reduces all-cause mortality in patients with type 2 diabetes with a higher impact on women

Doctor D. Garcia Vega (Ourense, ES)

Abstract Slides Video

Presentation thumbnail

Associations between C-reactive protein levels and mortality in individuals with atherosclerotic cardiovascular disease and chronic kidney disease: results from the UK Discover database

Professor K. Ray (London, GB)

Abstract Slides Video

Presentation thumbnail

Cumulative adiposity burden and cardiovascular risk trajectories: validating the 2025 clinical obesity criteria

Doctor J. Yang (Shanghai, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiorenal-metabolic triad: the global health challenge

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

Congress Presentation

The floor is yours: bring your questions on management of cardiovascular-kidney-metabolic syndrome - expert panel

Congress Session

Novel therapies in managing patients with cardiovascular-kidney-metabolic (CKM) syndrome and heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources